CM
Conor McNamara RBC Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
31
Avg Return
Past Year
Past Year
8.9%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
77.4%
Neutral
22.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Health Information Services
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Upgraded
| $73 |
11%
upside
| 4 | +23% |
0
%
| 3 Sep ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $5 |
27%
upside
| 1 | +91% |
0
%
| 12 Aug ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $255 |
9%
upside
| 2 | +32% |
0
%
| 8 Aug ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $3 |
57%
upside
| 2 | -11% |
0
%
| 7 Aug ‘25 5 months ago |
|
|
|
Sector Perform
Maintained
| $46 |
55%
downside
| 1 | – |
–
| 7 Aug ‘25 5 months ago |
|
|
|
Outperform
Upgraded
| $87 |
16%
upside
| 4 | +10% |
0
%
| 6 Aug ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $17 |
37%
upside
| 3 | -12% |
0
%
| 4 Aug ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $126 |
11%
downside
| 4 | +8.2% |
0
%
| 1 Aug ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $409 |
26%
upside
| 3 | +0.94% |
0
%
| 1 Aug ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $204 |
22%
upside
| 3 | +2.9% |
0
%
| 30 Jul ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $637 |
3%
upside
| 1 | +43% |
0
%
| 24 Apr ‘25 8 months ago |
|
|
|
Outperform
Reiterated
| $250 |
5%
upside
| 2 | +5% |
0
%
| 23 Apr ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $61 |
81%
upside
| 1 | -16% |
0
%
| 13 Feb ‘25 11 months ago |
|